医学
比例危险模型
内科学
肾脏疾病
动静脉瘘
肾移植
导管
肾病科
对数秩检验
肾
移植
泌尿科
外科
心脏病学
作者
Ramón Roca‐Tey,Emma Arcos,Jordi Comas,Jaume Tort
标识
DOI:10.1177/11297298221118738
摘要
Background: Data about vascular access (VA) use in failed kidney transplant (KT) patients returning to haemodialysis (HD) are limited. We analysed the VA profile of these patients, the factors associated with the likelihood of HD re-initiation through fistula (AVF) and the effect of VA in use at the time of KT on kidney graft (KTx) outcome. Method: Data from the Catalan Registry on failed KT patients restarting HD and incident HD patients with native kidney failure were examined over an 18-year period. Results: The VA profile of 675 failed KT patients at HD re-initiation compared with that before KT and with 16,731 incident patients starting HD was (%): AVF 79.3 versus 88.6 and 46.2 ( p = 0.001 and p < 0.001), graft AVG 4.4 versus 2.6 and 1.1 ( p = 0.08 and p < 0.001), tunnelled catheter TCC 12.4 versus 5.5 and 18.0 ( p = 0.001 and p < 0.001) and non-tunnelled catheter 3.9 versus 3.3 and 34.7 ( p = 0.56 and p < 0.001). The likelihood of HD re-initiation by AVF was significantly lower in patients with cardiovascular disease, KT duration >5 years, dialysed through AVG or TCC before KT, and females. The analysis of Kaplan-Meier curves showed a greater KTx survival in patients dialysed through arteriovenous access than in patients using catheter just before KT (λ 2 = 5.59, p = 0.0181, log-rank test). Cox regression analysis showed that patients on HD through arteriovenous access at the time of KT had lower probability of KTx loss compared to those with catheter (hazard ratio 0.71, 95% CI 0.55–0.90, p = 0.005). Conclusions: The VA profile of failed KT patients returning to HD and incident patients starting HD was different. Compared to before KT, the proportion of failed KT patients restarting HD with AVF decreased significantly at the expense of TCC. Patients on HD through arteriovenous access at the time of KT showed greater KTx survival compared with those using catheter.
科研通智能强力驱动
Strongly Powered by AbleSci AI